Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis.
作者信息
Hamdi Wafa, Maatallah Kaouther
机构信息
Department of Rheumatology, Tunis El Manar University, Faculty of Medicine of Tunis, Kassab Institute of Orthopedics; 2010 Ksar Said Manouba-Tunisia.
出版信息
Anatol J Cardiol. 2019 Sep;22(4):192-193. doi: 10.14744/AnatolJCardiol.2019.78703.
Abstract
摘要
相似文献
1
Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis.亚临床动脉粥样硬化：强直性脊柱炎患者的潜在威胁。
Anatol J Cardiol. 2019 Sep;22(4):192-193. doi: 10.14744/AnatolJCardiol.2019.78703.
2
Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices.强直性脊柱炎亚临床动脉粥样硬化的评估：与疾病活动指数的相关性
Reumatismo. 2013 Jul 23;65(3):105-12. doi: 10.4081/reumatismo.2013.105.
3
Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis.强直性脊柱炎患者的颈动脉内膜中层厚度：系统评价和更新的荟萃分析。
J Atheroscler Thromb. 2019 Mar 1;26(3):260-271. doi: 10.5551/jat.45294. Epub 2018 Aug 8.
4
Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies.疾病活动度低的强直性脊柱炎患者亚临床动脉粥样硬化并未加速：新数据及已发表研究的荟萃分析
J Rheumatol. 2015 Nov;42(11):2098-105. doi: 10.3899/jrheum.150316. Epub 2015 Oct 1.
5
The Relationship of Ankylosing Spondylitis and Subclinical Atherosclerosis: A Systemic Review and Meta-Analysis.强直性脊柱炎与亚临床动脉粥样硬化的关系：一项系统评价和荟萃分析
Angiology. 2019 Jul;70(6):492-500. doi: 10.1177/0003319718814309. Epub 2018 Nov 29.
6
Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.血浆致动脉粥样硬化指数：强直性脊柱炎亚临床动脉粥样硬化的有用标志物：AIP 与 AS 中的 cIMT 相关。
Clin Rheumatol. 2018 May;37(5):1273-1280. doi: 10.1007/s10067-018-4027-0. Epub 2018 Feb 12.
7
Evaluation of subclinical atherosclerosis using ultrasound radiofrequency data technology in patients diagnosed with ankylosing spondylitis.利用超声射频数据技术对强直性脊柱炎患者亚临床动脉粥样硬化的评估。
J Ultrasound Med. 2019 Mar;38(3):703-711. doi: 10.1002/jum.14754. Epub 2018 Sep 4.
8
Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.强直性脊柱炎患者血清骨保护素与动脉僵硬度、临床前期动脉粥样硬化及疾病活动度的关系
Clin Rheumatol. 2016 Sep;35(9):2235-41. doi: 10.1007/s10067-016-3198-9. Epub 2016 Feb 4.
9
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis.肿瘤坏死因子阻断剂与强直性脊柱炎患者亚临床动脉粥样硬化的进展。
Ann Rheum Dis. 2015 Jan;74(1):119-23. doi: 10.1136/annrheumdis-2013-203934. Epub 2013 Oct 3.
10
Epicardial adipose tissue thickness as a new risk factor for atherosclerosis in patients with ankylosing spondylitis.心外膜脂肪组织厚度作为强直性脊柱炎患者动脉粥样硬化的一个新的危险因素。
J Back Musculoskelet Rehabil. 2019;32(2):237-243. doi: 10.3233/BMR-160650.
引用本文的文献
1
Adhesion molecules and atherosclerosis in ankylosing spondylitis: implications for cardiovascular risk.黏附分子与强直性脊柱炎的动脉粥样硬化：心血管风险的意义。
Rheumatol Int. 2024 Oct;44(10):1837-1848. doi: 10.1007/s00296-024-05693-3. Epub 2024 Aug 24.
本文引用的文献
1
Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis.强直性脊柱炎患者亚临床动脉粥样硬化性心血管疾病的评估
Anatol J Cardiol. 2019 Sep;22(4):185-191. doi: 10.14744/AnatolJCardiol.2019.13367.
2
Establishing the interchangeability of arterial stiffness but not endothelial function parameters in healthy individuals.在健康个体中建立动脉僵硬度而非内皮功能参数的可互换性。
BMC Cardiovasc Disord. 2019 Aug 6;19(1):190. doi: 10.1186/s12872-019-1167-3.
3
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.肿瘤坏死因子抑制剂与脊柱关节病中补体激活减少有关：一项观察性研究。
PLoS One. 2019 Jul 23;14(7):e0220079. doi: 10.1371/journal.pone.0220079. eCollection 2019.
4
The Relationship of Ankylosing Spondylitis and Subclinical Atherosclerosis: A Systemic Review and Meta-Analysis.强直性脊柱炎与亚临床动脉粥样硬化的关系：一项系统评价和荟萃分析
Angiology. 2019 Jul;70(6):492-500. doi: 10.1177/0003319718814309. Epub 2018 Nov 29.
5
Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis.强直性脊柱炎患者的颈动脉内膜中层厚度：系统评价和更新的荟萃分析。
J Atheroscler Thromb. 2019 Mar 1;26(3):260-271. doi: 10.5551/jat.45294. Epub 2018 Aug 8.
6
Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls.接受肿瘤坏死因子-α拮抗剂治疗的强直性脊柱炎患者与健康对照者在颈动脉粥样硬化方面的差异。
Medicine (Baltimore). 2018 Jul;97(27):e11250. doi: 10.1097/MD.0000000000011250.
7
Cardiovascular risk in patients with rheumatoid arthritis.类风湿关节炎患者的心血管风险
Semin Immunopathol. 2017 Jun;39(4):447-459. doi: 10.1007/s00281-017-0632-2. Epub 2017 Apr 28.
8
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients.抗肿瘤坏死因子α治疗可降低非糖尿病性强直性脊柱炎患者血清视黄醇结合蛋白4水平。
Ann Rheum Dis. 2014 May;73(5):941-3. doi: 10.1136/annrheumdis-2013-204484. Epub 2013 Dec 9.
9
Inflammation and atherosclerosis--revisited.炎症与动脉粥样硬化——再探讨
J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):170-8. doi: 10.1177/1074248413504994. Epub 2013 Oct 31.
10
Cardiovascular risk profile in patients with spondyloarthritis.脊柱关节炎患者的心血管风险特征。
Joint Bone Spine. 2014 Jan;81(1):57-63. doi: 10.1016/j.jbspin.2013.03.019. Epub 2013 Jun 2.
Zotero 插件